chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a healthcare worker refers to a patient of unknown age and gender. Medical history and concurrent condition of the patient was not reported. On an unknown date the patient was vaccinated with dose one and two of GARDASIL (dose, route, lot# and expiry date unknown) one year apart. No adverse experience reported. No product quality complaint (PQC) involved. Additional information is not expected as we are not permitted to contact the physician.
Approximately 8 hours after vaccine I had urinary incontinence, no muscle strength in lower limbs, blurred vision. Fell upon trying to stand when getting out of bed, unable to walk. needed help of my daughter to get back in bed. Needed to where Depends for 2 days.   These side effects last 2 days then gradually improved. Common side effects of Temp 99, Headache, and chills,  and malaise.
has lost pounds , which is something difficult for her; can´t get herself around /feel she drag herself; feeling some fatigue that went worst /usually have some fatigue but not like the one she has been experiencing after the shot /still have the fatigue; could not sleep or eat for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep or eat for 2 days), WEIGHT DECREASED (has lost pounds , which is something difficult for her), FEELING ABNORMAL (can´t get herself around /feel she drag herself) and FATIGUE (feeling some fatigue that went worst /usually have some fatigue but not like the one she has been experiencing after the shot /still have the fatigue) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stroke (Had a stroke 3 years ago).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INSOMNIA (could not sleep or eat for 2 days) and FATIGUE (feeling some fatigue that went worst /usually have some fatigue but not like the one she has been experiencing after the shot /still have the fatigue). On 09-Feb-2021, the patient experienced WEIGHT DECREASED (has lost pounds , which is something difficult for her) and FEELING ABNORMAL (can´t get herself around /feel she drag herself). On 06-Feb-2021, INSOMNIA (could not sleep or eat for 2 days) had resolved. At the time of the report, WEIGHT DECREASED (has lost pounds , which is something difficult for her), FEELING ABNORMAL (can´t get herself around /feel she drag herself) and FATIGUE (feeling some fatigue that went worst /usually have some fatigue but not like the one she has been experiencing after the shot /still have the fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product include pill for blood thinner.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up was received on 22 Apr 2021 included no new information and patient denied further follow up.
pt recv vax 2APR98 & 6APR98 pt c/o fever 105, rash on legs & diaper area;dx w/BOM;follow up done 10APR98 still w/BOM referred to ENT;
Dizzy; rapid heartbeat; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received bnt162b2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6206), via an unspecified route of administration in left arm on 10Mar2021, as dose 1, single for COVID-19 immunization (age at vaccination: 67 years) and LISINOPRIL (LISINOPRIL, route of administration, lot number and expiry date was not reported) on an unspecified date for high blood pressure (hypertension) once a day (it is 20/12.5). Medical history included high blood pressure. Concomitant medications were not reported. The patient experienced dizzy and rapid heartbeat on an unspecified date in 2021. The patient stated the concern that she took this 1st vaccine like 3 weeks ago and scheduled to get another one Thursday 01Apr2021. She was wondering that one point she had like dizzy, rapid heartbeat. She did not know that she used to take the blood pressure medicine when you do it, she takes it in the morning, but then she took it the other day, she did not know if it was the blood pressure medicine or not. Two or three days after she get the rapid heartbeat and dizziness. She got the dizziness when she first got it, so all of those typical symptoms and she wanted to know if it was the typical symptom. Therapeutic measures were taken as a result of event dizzy. The patient stated that she did lab test recently may be in January, but she did not know, and her doctor has all the information. Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
pt recvd vax & was dx w/ cellulitis characterized by redness & swelling in arm of inject; MD revised dx to local erythematous rxn;
slight nausea; After the second vaccine: body aches and pains; pain in area of injection; Neck pain; migraine; Severe Headahche; fever of 102 Fahrenheit; Vaginal bleeding; uterine cramping (I don't have menstrual periods due to birth control); sharp pain in bottom of left foot; congestion (felt like a head cold); decrease in appetite; Fatigue; Drowsiness /Slept all day; Cold sweat; Chills; Hot flashes; felt like a head cold; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 19-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0172) via an unspecified route of administration, administered in the left arm on 23Apr2021 12:00 (at the age of 19-years-old) as dose 2, single and for COVID-19 immunization. The patient's medical history included ADHD (attention deficit hyperactivity disorder), generalised anxiety disorder, PTSD (mental disorder), depression, from an unknown date and unknown if ongoing and inflammation in bowel from an unknown date and unknown if ongoing currently receiving treatment and figuring out official diagnosis. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EP7533) via an unspecified route of administration, administered in the left arm on 02Apr2021 12:00 PM (at the age of 19-years-old) as dose 1, single and for COVID-19 immunization. Concomitant medications included quetiapine fumarate (SEROQUEL), budesonide, omeprazole, medroxyprogesterone acetate (DEPO-PROVERA), taken for an unspecified indication, start and stop date were not reported. On 24Apr2021 11:00, the patient experienced slight nausea, after the second vaccine: body aches and pains, pain in area of injection, neck pain, migraine, severe headahche, fever of 102 fahrenheit, vaginal bleeding, uterine cramping (i don't have menstrual periods due to birth control), sharp pain in bottom of left foot, congestion (felt like a head cold), decrease in appetite, fatigue, drowsiness /slept all day, cold sweat, chills, hot flashes, felt like a head cold. On 24Apr2021, the patient underwent lab tests and procedures which included body temperature: 102 fahrenheit. No other vaccine in four weeks. other medications in two weeks were taken as seroquel, budesonide, omeprazole, depo-provera. No covid prior vaccination nor tested for covid post vaccination and patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies reported. No treatment reported for the adverse events. The outcome of the events was reported as recovering.  Follow-up attempts completed. No further information expected.
received the first dose / on 03/09/20 / I did / get my 2nd Shingrix / on Sunday; made my arm sore, like someone slugged me; This case was reported by a consumer and described the occurrence of pain in arm in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first dose received intramuscular on 9th March 2020 in left arm).   On 13th December 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 13th December 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. In December 2020, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient had not received the second dose of Shingrix till the time of reporting (inappropriate schedule of vaccine). VAERS details reported for 1st dose. The patient did not have lot number or expiration date information to provide for the 1st dose. The patient gave consent to follow up with health case professional. Follow up was received from the patient on 18th December 2020 and the patient stated she finally got 2nd Shingrix vaccine, later than the recommended interval, which led to lengthening of vaccination schedule. The patient stated surely made her arm sore, like someone slugged her but the issue was resolved. No further information was obtained from the patient. The patient consented to follow up.
1. November 24th - Normal (shot administered at pharmacy at approx. 2:15 pm) 2. November 25th -  Abnormal (approx. 2:30 pm) aching over entire body, fever up to 103, weakness, extreme fatigue) 3. November 26th -  Slightly better (fever broke, weak and fatigued, underarm nodules both left and right arms, nodules and pain felt in upper stomach) 4. November 27, 28, 29th - Still in pain with upper stomach nodules, putting hot compresses on, taking Ibuprofen, taking amoxicillin 500 mg not my prescription but available from another doctor visit. I tool two a day AM and PM for four days, then stopped. 5. November 30th - Submitted a written report via online web site, which went to my doctor's office. I wrote in the report the discomfort with the nodules, in particular in my upper stomach area. I spoke with the Doctor's office and they were going to call me back. 6. December 1-7 - Feel better but upper stomach area feels swollen and Tuesday, December 7th, I felt a nodule and the area feels sensitive to the touch.
I had dizziness/lightheaded 10 minutes after dose. Dizziness went away 40 minutes later. 24 hours after dose had body aches. 2 days after dose I had blurred vision in Rt eye and then noticed that Rt eye was fully dilated and Lt eye was normal. Rt eye not responding to light. Went to ED and had 2 CT scans that were normal. They sent me where I had a third CT scan which was normal. I saw ophthalmology and my optic nerve was normal and eyes looked good, but Rt eye still didn't react to light. they ruled out pharmacological and said that it is something neurological. They still don't know exactly what is going on. While at the hospital, I started having urinary retention and now have a foley placed. I have follow ups with neurology, urology and ophthalmology and have orders for MRI of brain and neck.
Tested NAAT positive for COVID 11/30/21 after being fully vaccinated.
Patient believes that the shot was not injected into her deltoid muscle, but "higher up near the bone and entered the joint fluid between her bones." She claims that this resulted in her losing range of motion in her arm and required her to seek physical therapy.
Wheals over face & warms. Itching. Treatment: Prednisone po taper. DEPO-MEDROL. OTC BENADRYL.
Patient called 9/21/06 with 1-2 day symptoms of stiff neck, some shoulders and neck, low grade fever (100.0) and chills.  TD vaccine given 9/15 (along with polio and typhoid). Patient said PCP on 9/21 (doctor) and he told patient symptoms were sue to Td vaccine.  He ordered a CT scan.
The night patient received the vaccine, she experienced light-headedness, nausea, shortness of breath and visited an urgent care. Urgent Care triaged the patient to the ER after running "several tests" but once at the ER her vitals stabilized and patient was discharged right away. Patient is fine now
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "diabetes" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Unknown Results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within a few days of the first dose of the vaccine patient noticed extreme thirst, then increased urination frequency.  Patient noticed unintended weight loss starting 2 weeks after first dose, and totaled 20 pounds in 5 weeks.  Patient noticed some burry vision at night.   Symptoms seems to lessen 2-3 weeks after first dose, but returned with increased intensity after second dose.   Patient consulted a physician and lab work and blood sugar testing was ordered.  Blood sugars were as high as 400 and A1C of 11.  Patient went on a low extremely low carb no sugar diet for three days while waiting to see physician.   Patient continued to monitor blood sugars.  Blood sugars started to lower remained in the 170-260 range.   Physician ordered repeat lab work and suspects Adult Onset Type 1 diabetes.  Patient was placed on a long acting and quick acting insulin on 2-15-21.  23 Days after second dose.
Large rash near injection site-- probably 4 inches in diameter, feels similar to a mosquito bite (slightly painful and itchy)
Immediately after injection, patient stated her arm hurt and she felt pressure at one side. The next day she had decreased energy ad had waves of nausea but no vomiting. Decreased energy lasted 2 weeks. Pain radiated from elbow to neck x 1 week. Currently complains of pressure at injection site and pain when moving arm. Denies swelling. Mass, arm down to site. Has seen chiropractor and GI specialist since incident . No treatment received. Still with symptoms of pain.
Patient received her second dose of the Pfizer vaccine today at 1330, she waited the required 15 minute observation time, was feeling fine and left. She returned to the vaccine clinic around 1415 reporting that she was having trouble breathing. Security called the charge nurses and alerted them that a patient needed assistance. Writer came out to patient who was seated in her car. We assessed patient who was visibly having difficulty breathing and was unable to respond to questions without difficulty breathing. Emergency medication box was opened and epinephrine was prepped. We assessed patients allergies and recent medications taken. Patient denied hx of breathing problems or anxiety. Pt denied chest pain. Per protocol for potential allergic reaction, 0.3ml of epi was given at approximately 1426 via IM injection in the pt's left arm. ED triage nurse was called and asked to come assist. Two ED technicians with stretcher arrived and with writer  accompanying them transported pt to ED.
A non-serious spontaneous report of administration of expired vaccine was received from a registered nurse/health professional concerning a seven-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 29-Mar-2010. On 31-Mar-2010, the patient received expired H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable and the event was considered to be resolved.
fever as high as 102F; This case was reported by a other health professional via call center representative and described the occurrence of fever in a 80-year-old male patient who received Herpes zoster (Shingrix) (batch number 2737P, expiry date 22nd January 2022) for prophylaxis.   On 25th June 2020, the patient received the 1st dose of Shingrix. On 26th June 2020, 1 days after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 79 or 80 years. The patient experienced fever one day after receiving the first dose of Shingrix. The body temperature was reported as 102F. The reporter consented to follow up.
CHILLS, FEVER, REDNESS RADIATING AROUND TO OTHER SIDE OF ARM WITH RASH, SORE ARM, ACHING BONES, DECREASED APPETITE, ALL THIS LASTING FROM 9/24/19 AM TO 9/27/19 AM; 092619  SWEATING TO THE POINT OF SOAKING SHEETS AND BEDCLOTHES AND HAVING TO WAKE UP TO CHANGE ALL; OKAY FEELING ON 92719 BUT STILL RASH LARGE AND PRESENT
fever of 100 degrees Fahrenheit; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (fever of 100 degrees Fahrenheit) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (fever of 100 degrees Fahrenheit). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever of 100 degrees Fahrenheit) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Itcy,rash; Rash got worse , almost all his back and legs; Warm  to the touch; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itcy,rash), CONDITION AGGRAVATED (Rash got worse , almost all his back and legs) and SKIN WARM (Warm  to the touch) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included SERTRALINE, ATORVASTATIN, OLANZAPINE, CLONIDINE HYDROCHLORIDE (CLONIDINE [CLONIDINE HYDROCHLORIDE]) and CARVEDILOL for an unknown indication.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced RASH PRURITIC (Itcy,rash), CONDITION AGGRAVATED (Rash got worse , almost all his back and legs) and SKIN WARM (Warm  to the touch). The patient was treated with ECONAZOLE NITRATE (topical) at a dose of 1 percent and FLUOCINONIDE (FLUCINONIDE) at a dose of 0.5 percent. At the time of the report, RASH PRURITIC (Itcy,rash) had not resolved and CONDITION AGGRAVATED (Rash got worse , almost all his back and legs) and SKIN WARM (Warm  to the touch) outcome was unknown.            Patient took the supplements as a concomitant.   This case was linked to MOD-2021-294479 (Patient Link).
A report has been received from a Health Professional concerning a child, subject of unknown gender, who had been receiving nasal FLUMIST Quadrivalent.  FLUMIST Quadrivalent started on 20-JAN-2015. It was stated that the patient experienced administration of expired product (lot-CK2009) expired on 19-JAN-2015 which started on 20-JAN-2015. The outcome of the event of administration of expired product is unknown. The report was considered to be non-serious.
The parents were contacted and made aware of the incorrect dosage.  At the time there were no reported symptoms.
Swollen lip and chin about 12 hours after vaccine; doctor has advised to try Tylenol PM
10 days following-  injection site has a large bump under the skin, skin is red and hot to touch, dime sized area.   Day 2- red area is raised  larger, hot to touch, lump is painful.   Day 3- red area is much larger and spreading down arm, a raised ring around the site is present.  Dr. is notified and prescribes Antibiotic for bacterial infections.  Day 4 - red area is still spreading but the pain and swelling has subsided.  Day 5,  redness is subsiding but present.  Pain and swelling gone.
This is in follow-up to report(s) previously submitted on 10/12/2007. Information has been received from the mother concerning her 18 year old daughter who on 21-DEC-2006, was vaccinated with the first dose of Gardasil, the second dose of Gardasil, the second dose on 27-FEB-2007, and the third dose on 19-JUL-2007. On 21-AUG-2007, the patient inadvertently received a fourth dose of Gardasil. After receiving the fourth dose, the patient developed acne on her face. Unspecified medical attention was sought. No laboratory diagnostic studies were performed. Follow up information states that she has only had her menstrual cycle for two days and it was very light. The mother reported that her daughter never had irregular periods prior to the vaccination. As of 28-SEP-2007, the patient had not recovered. No product quality complaint was involved. The patient's twin sister also received 4 doses of Gardasil and developed acne on her face (WAES 0710USA00171). Additional information has been requested.
A report was received from a health care professional on 2/24/04 concerning up to 8 vaccinees under 4 years of age and of unknown gender who inadvertently received a dose of Fluvirin vaccine on an unreported day in December 2003. On an unspecified day in December 2003, up to 8 vaccinees were inadvertently administered Fluvirin. The outcome of the event was not reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/22/04: Further information was received from a health care professional indicating that the vaccinee was a 39 month old female who inadvertently received 0.5ml Fluvirin on 12/15/03. No adverse events were reported at the time of the event. No follow up pending. All information received.
Fever, night sweats, got dizzy in the morning and fell over, much pain in injection arm